Cite
MLA Citation
Howard L Kaufman et al.. “Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2.” Journal for immunotherapy of cancer, vol. 2, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100137793150.0x000001